Flu's bad news but shot in arm for Gilead  Gilead Sciences climbed nearly 4 percent to close at $47.53; they're collecting on Tamiflu, the influenza drug the biotech company invented Lawsuit Vs. Gilead To Proceed  The U.S. Supreme Court has refused to halt a securities-fraud suit by investors who claim the biotech company inflated its stock price in 20... Gilead To Buy CV Therapeutics For $1.4 B  Biotechnology company Gilead Sciences, known for its HIV drugs, said it will pay $20 per share in cash for Palo Alto-based CV Therapeutics Another Yelp lawsuit afer negative review

Gilead beats Street 4Q forecasts  Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $3.11 billion. It had profit of $2.34 per share Gilead Sciences beats estimates for 4th-quarter earnings   34 percent increase in profit, trouncing expectations, as sales of its blockbuster hepatitis C drugs soared in Japan and offset lower sales in the U Gilead Sciences beats Street 3Q forecasts  Propelled by sales of hepatitis C pills, Gilead posted an impressive 68% increase in third-quarter profit and hiked its revenue forecast yet... Gilead profit beats Wall Street forecasts  Blockbuster hepatitis C medicine Harvoni lifted Gilead Sciences’ second-quarter profit by 23% as total revenue for the biotech drugmaker jumped 26% Visa 1Q profit rises 11 percent, sets 4-for-1 stock split  Consumer spending grew on the credit and debit card processor's massive payment network. Visa earned $1.57 billion, or $2.53 per share Visa posts lower 4Q profit; beats Street views  The profit fell about 10%, weighed down by one-time litigation expenses.The company also announced a $5 billion share buyback program Visa Sinks the Dow Jones  Visa (NYSE: V ) has been the biggest drag on the Dow so far: The credit card giant has plunged about 4% 4 hurt in Foster City construction accident Map of Triton Drive Foster City   94404: Four workers were hurt Monday during the partial collapse of a wood-frame restaurant under construction Gilead Sciences CEO joins billionaires' ranks  John Martin is $1.2 billion, based on his stake in the company, which recently released a potential blockbuster drug to treat Hepatitis C Gilead profit beats estimates Visa 4Q profit down 28 pct on large tax provision Gilead to buy Pharmasset for $11 billion year 2017 Top ^ Feb.7 year 2016 Top ^ Feb.2 year 2015 Top ^ Oct.27 Jul.28 Jan.29 year 2014 Top ^ Oct.29 Aug.18 Jun.16 Mar.3 Feb.5 year 2013 Top ^ Oct.30 year 2011 Top ^ Nov.21   Gilead Sciences Inc. has agreed to pay about $11 billion for drug developer Pharmasset Inc. in a huge bet on experimental hepatitis C treatments Gilead Timeline (13)
year 2009 Top ^
	Apr.28
	Apr.22
	Mar.12
	Jan.12

Pediatric dentist Yvonne Wong has sued the review site and two individuals, accusing them of libel over a negative review of her practice

Yelp Timeline (17) U.S. in January, 2009 (104) Peninsula Business Lawsuit Timeline (40)

• U.S. in June, 2008 (97)